Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-02BCYC144Perry Jennifer Scott plan to sell securities of BICYCLE THERAPEUTICS PLC under Form 144MEDIUM
Perry Jennifer Scott filed Form 144 to notify SEC of plan to sell 1500 units of BICYCLE THERAPEUTICS PLC securities around 2026-04-02, with aggregate market value of $7,357.95. The total outstanding units is 50269082.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Small CapBiotechnology
2026-04-02REPL144Christopher Sarchi plan to sell securities of Replimune Group Inc. under Form 144MEDIUM
Christopher Sarchi filed Form 144 to notify SEC of plan to sell 18500 units of Replimune Group Inc. securities around 2026-04-02, with aggregate market value of $142,450.00. The total outstanding units is 82572619.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Micro CapBiotechnology
2026-04-02NRIX144CHRISTINE RING plan to sell securities of NURIX THERAPEUTICS INC under Form 144MEDIUM
CHRISTINE RING filed Form 144 to notify SEC of plan to sell 8148 units of NURIX THERAPEUTICS INC securities around 2026-04-02, with aggregate market value of $126,131.04. The total outstanding units is 102843012.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 ...
Small CapBiotechnology
2026-04-02IMNM144Rosett Max plan to sell securities of Immunome Inc. under Form 144MEDIUM
Rosett Max filed Form 144 to notify SEC of plan to sell 65000 units of Immunome Inc. securities around 2026-04-02, with aggregate market value of $4,723,550.00. The total outstanding units is 113133199.0. The amount planned to be sold represents 0.06% of total outstanding units; ...
Mid CapBiotechnology
2026-04-02CAPR144Karimah Es Sabar plan to sell securities of CAPRICOR THERAPEUTICS INC under Form 144MEDIUM
Karimah Es Sabar filed Form 144 to notify SEC of plan to sell 7529 units of CAPRICOR THERAPEUTICS INC securities around 2026-04-02, with aggregate market value of $226,773.48. The total outstanding units is 57510635.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in pas...
Small CapBiotechnology
2026-04-02Replimune Group, Inc.144Christopher Sarchi plan to sell securities of Replimune Group Inc. under Form 144DuplicateMEDIUM
Christopher Sarchi filed Form 144 to notify SEC of plan to sell 18500 units of Replimune Group Inc. securities around 2026-04-02, with aggregate market value of $142,450.00. The total outstanding units is 82572619.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Micro CapBiotechnology